Form 4: Quest Diagnostics Director Vicky B. Gregg Sells 1,250 Shares

Sentiment:

SEC Form 4 Filing


Director Vicky B. Gregg sold 1,250 shares of Quest Diagnostics Inc. (DGX) at a price of $164.568 on February 5, 2025, leaving her with 16,867 shares.

Summary

  • On February 5, 2025, Vicky B. Gregg, a director of Quest Diagnostics Inc. (DGX), sold 1,250 shares of common stock.
  • The sale price was $164.568 per share.
  • Following the transaction, Ms. Gregg directly owns 16,867 shares of Quest Diagnostics.
  • The transaction was reported on February 7, 2025.

Sentiment

Score: 5

Explanation: This is a neutral event. A director selling shares doesn't necessarily indicate a negative outlook, as it could be for personal financial planning. Without additional context, it's neither particularly positive nor negative.

Industry Context

This is a standard Form 4 filing, indicating a change in beneficial ownership by a company insider. These filings are closely watched by investors for signals about management's view of the company's prospects, although individual sales can be for a variety of personal financial reasons.

Stakeholder Impact

  • The sale of shares by a director could have a minor impact on shareholder confidence, depending on the size of the sale and the overall market sentiment.

Key Dates

DateDescription
02/05/2025Date of transaction: Vicky B. Gregg sold 1,250 shares of Quest Diagnostics common stock.
02/07/2025Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.